Cel Sci CVM
NYSE CVM
$1.32 -0.08 (-5.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Cel Sci (CVM) Gains from Investment Securities (2010 - 2023)

Updated

Cel Sci's Gains from Investment Securities came in at $3.91 million for fiscal Q4 2020 (quarter ended Sep 30, 2020), down 4.0% from $4.08 million a year earlier.

Analysis

Cel Sci (CVM) Gains from Investment Securities (2010 - 2023) Analysis & Trends

For FY2020 (ended Sep 30, 2020), Cel Sci's Gains from Investment Securities was $349,078, down 54.1% from FY2019.

  • Going back by fiscal year, Gains from Investment Securities was $760,603 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cel Sci 58.11 Mn 32.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 6,000.00
Jun 30, 2022 733,582.00
Mar 31, 2022 -2,195.00
Dec 31, 2021 364,596.00
Sep 30, 2021 -1.69 Mn
Jun 30, 2021 -1.12 Mn
Mar 31, 2021 3.04 Mn
Dec 31, 2020 -932,836.00
Sep 30, 2020 -3.91 Mn
Jun 30, 2020 5.85 Mn
Mar 31, 2020 -3.05 Mn
Dec 31, 2019 766,509.00
Sep 30, 2019 -4.08 Mn
Jun 30, 2019 -7.91 Mn
Mar 31, 2019 -967,171.00
Dec 31, 2018 5.56 Mn
Sep 30, 2018 -8.83 Mn
Jun 30, 2018 -8,618.00
Mar 31, 2018 1.15 Mn
Dec 31, 2017 -958,230.00
API Access

Cel Sci Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=CVM&period=max&api_key=YOUR_API_KEY